Search results for " Inhalation"

showing 10 items of 231 documents

Development of polymer-based nanoparticles for Zileuton delivery to the lung : PMeOx and PMeOzi surface chemistry reduces interactions with mucins

2021

In this paper, two amphiphilic graft copolymers were synthesized by grafting polylactic acid (PLA) as hydrophobic chain and poly(2-methyl-2-oxazoline) (PMeOx) or poly(2-methyl-2-oxazine) (PMeOzi) as hydrophilic chain, respectively, to a backbone of α,β-poly(N-2-hydroxyethyl)-D,L-aspartamide (PHEA). These original graft copolymers were used to prepare nanoparticles delivering Zileuton in inhalation therapy. Among various tested methods, direct nanoprecipitation proved to be the best technique to prepare nanoparticles with the smallest dimensions, the narrowest dimensional distribution and a spherical shape. To overcome the size limitations for administration by inhalation, the nano-into-micr…

Poly(2-oxazoline)sPolymers116 Chemical sciencesPharmaceutical ScienceMedicine (miscellaneous)Nanoparticle02 engineering and technology01 natural scienceschemistry.chemical_compoundDrug Delivery SystemsNanoparticlePolylactic acidCopolymerPolyaminesHydroxyureaGeneral Materials SciencePoly(2-oxazine)sDRUG-DELIVERYCells Culturedchemistry.chemical_classificationDrug CarriersCHALLENGESAIRWAY MUCUSPolymer021001 nanoscience & nanotechnologyGraftingDIFFUSIONPolyaspartamidePULMONARY DELIVERYDrug deliveryMolecular Medicine0210 nano-technologyHydrophobic and Hydrophilic Interactionsmedicine.drugLung inflammationPolyestersBiomedical EngineeringINHIBITIONBioengineeringBronchi010402 general chemistryPolylactic acidZileutonAmphiphileAdministration InhalationmedicineHumansPoly(2-oxazoline)RELEASEMucinsBronchial DiseasesEpithelial CellsZileuton0104 chemical scienceschemistryChemical engineeringSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoNanoparticlesASTHMAPoly(2-oxazine)
researchProduct

Inhalable polymeric microparticles as pharmaceutical porous powder for drug administration

2022

In this work, the production of inhalable polymeric microparticles with modulable porosity is described. The starting polymeric material was the PHEA-g-RhB-g-PLA graft copolymer, which was suitably processed by spray drying (SD). Thanks to the addition of AB (weight percentage equal to 10 and 20 % with respect to the polymer) in the liquid feed, three biocompatible matrices were obtained with an increasing porosity in terms of pore volume (from 0.015 to 0.024 cc/g) and pore average diameter (from 1.942 to 3.060 nm), a decreasing tapped density values (from 0.75 to 0.50), and favorable aerosolization characteristics. These differences were high-lighted also by a significant increase in the r…

Porous microparticlesDrug CarriersPolymersSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoAdministration InhalationPharmaceutical SciencePulmonary administrationRapamycinPowdersParticle SizePorosityαβ-Poly(N-2-hydroxyethyl)-Dl-ASPARTAMIDE (PHEA)
researchProduct

Survey of neonatal respiratory care and surfactant administration in very preterm infants in the Italian neonatal network

2013

INTRODUCTION: Variation of respiratory care is described between centers around the world. The Italian Neonatal Network (INN), as a national group of the Vermont-Oxford Network (VON) allows to perform a wide analysis of respiratory care in very low birth weight infants. METHODS: We analyzed the dataset of infants enrolled in the INN in 2009 and 2010 and, for surfactant administration only, from 2006 to 2010 from 83 participating centers. All definitions are those of the (VON). A questionnaire analysis was also performed with a questionnaire on centers practices. RESULTS: We report data for 8297 infants. Data on ventilator practices and outcomes are outlined. Variation for both practices and…

Preterm infants; Ventilation; Ventilatory support; Medicine (all)Drug Utilization; Humans; Infant Mortality; Infant Newborn; Infant Very Low Birth Weight; Intubation Intratracheal; Italy; Oxygen Inhalation Therapy; Pulmonary Surfactants; Respiration Artificial; Infant PrematureSettore MED/38 - Pediatria Generale E SpecialisticaInfant MortalityIntubation IntratrachealHumansInfant Very Low Birth WeightPrematureVery Low Birth WeightRespirationMedicine (all)Infant NewbornOxygen Inhalation TherapyInfantPreterm infantsPulmonary SurfactantsNewbornRespiration ArtificialDrug UtilizationVentilationnational survayIntratrachealVery preterm infant national survay neonatal respiratory careVentilatory supportItalyVery preterm infantArtificialPreterm infantneonatal respiratory careIntubationInfant Premature
researchProduct

A comparison of micropore membrane inlet mass spectrometry–derived pulmonary shunt measurement with riley shunt in a porcine model

2009

The multiple inert gas elimination technique was developed to measure shunt and the ratio of alveolar ventilation to simultaneous alveolar capillary blood flow in any part of the lung (V(A)'/Q') distributions. Micropore membrane inlet mass spectrometry (MMIMS), instead of gas chromatography, has been introduced for inert gas measurement and shunt determination in a rabbit lung model. However, agreement with a frequently used and accepted method for quantifying deficits in arterial oxygenation has not been established. We compared MMIMS-derived shunt (M-S) as a fraction of total cardiac output (CO) with Riley shunt (R-S) derived from the R-S formula in a porcine lung injury model.To allow a …

Pulmonary AtelectasisPulmonary CirculationSwineCapillary actionBlood PressureMass spectrometryVentilation/perfusion ratioMass SpectrometryAdministration InhalationVentilation-Perfusion RatiomedicineAnimalsCardiac OutputChromatographyMultiple inert gas elimination techniquebusiness.industryMicropore FiltersModels CardiovascularMembranes ArtificialLung InjuryBlood flowrespiratory systemOxygenDisease Models AnimalAnesthesiology and Pain MedicineAnesthesiaAnesthetics InhalationLinear ModelsPulmonary shuntGas chromatographyBlood Gas Analysismedicine.symptombusinessShunt (electrical)
researchProduct

Perioperative hyperoxia: Myths and realities

2017

Pulmonary Atelectasismedicine.medical_specialtyPartial PressureAcute Lung InjuryMEDLINEHyperoxiaPerioperative Care03 medical and health sciencesPostoperative Complications0302 clinical medicineMeta-Analysis as Topic030202 anesthesiologymedicineHumansMulticenter Studies as TopicSurgical Wound InfectionHypoxiaIntraoperative ComplicationsIntensive care medicineMeta-Analysis as TopicHyperoxiaClinical Trials as TopicDose-Response Relationship Drugbusiness.industryOxygen Inhalation TherapyGeneral MedicineMythologyPerioperativeOxygenPulmonary AlveoliVasoconstrictionPractice Guidelines as Topicmedicine.symptombusiness030217 neurology & neurosurgeryRevista Española de Anestesiología y Reanimación (English Edition)
researchProduct

New evidence in one-lung ventilation

2017

Mechanical ventilation in thoracic surgery has undergone significant changes in recent years due to the implementation of the protective ventilation. This review will analyze recent ventilatory strategies in one-lung ventilation. A MEDLINE research was performed using Mesh term "One-Lung Ventilation" including randomized clinical trials, metanalysis, reviews and systematic reviews published in the last 6 years. Search was performed on 21st March 2017. A total of 75 articles were initially found. After title and abstract review 14 articles were included. Protective ventilation is not simply synonymous of low tidal volume ventilation, but it also includes routine use of PEEP and alveolar recr…

Pulmonary Atelectasismedicine.medical_specialtySwinemedicine.medical_treatmentMEDLINElaw.inventionHypercapniaPositive-Pressure Respiration03 medical and health sciences0302 clinical medicineMeta-Analysis as TopicRandomized controlled trial030202 anesthesiologylawTidal VolumeAnimalsHumansMedicine030212 general & internal medicineExpirationIntensive care medicineRandomized Controlled Trials as TopicMechanical ventilationbusiness.industryGeneral Medicinerespiratory systemOne lung ventilationOne-Lung Ventilationrespiratory tract diseasesSystematic reviewCardiothoracic surgeryModels AnimalVentilation (architecture)Anesthesia Inhalationbusiness
researchProduct

Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignif…

2017

Chronic non-specific respiratory symptoms are difficult to manage. This trial aimed to evaluate the association between baseline fractional exhaled nitric oxide (FeNO) and the response to inhaled corticosteroids in patients with non-specific respiratory symptoms.In this double-blind randomised placebo-controlled trial, we enrolled undiagnosed patients, aged 18-80 years, with cough, wheeze, or dyspnoea and less than 20% bronchodilator reversibility across 26 primary care centres and hospitals in the UK and Singapore. Patients were assessed for 2 weeks before being randomly assigned (1:1) to 4 weeks of treatment with extrafine inhaled corticosteroids (QVAR 80 μg, two puffs twice per day, equi…

Pulmonary and Respiratory MedicineAdultMalePediatricsmedicine.medical_specialtyAdolescentmedicine.drug_classPlaceboNitric Oxidelaw.invention03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled trialDouble-Blind MethodlawBronchodilatorWheezeInternal medicineAdministration InhalationmedicineHumans030212 general & internal medicineAnti-Asthmatic AgentsRespiratory systemAdverse effectAgedAged 80 and overInhalationbusiness.industryBeclomethasoneMiddle Agedrespiratory systemRespiration Disordersrespiratory tract diseasesTreatment Outcome030228 respiratory systemExhalationExhaled nitric oxideFemaleHuman medicinemedicine.symptombusiness
researchProduct

Effect of beclomethasone dipropionate on the bronchial responsiveness to propranolol in asthmatics.

1990

The effect of four weeks of treatment with beclomethasone dipropionate (BDP, 500 micrograms twice daily) on the bronchial responsiveness to propranolol was examined in 16 patients with mild asthma in a placebo-controlled, double-blind crossover study. Propranolol was inhaled in doubling concentrations and the results were expressed as the cumulative dose producing a 20 percent fall in FEV1 (PC20). After four weeks of treatment with BDP, the mean FEV1 increased from 82.0 percent predicted to 88.1 percent predicted. The difference was significant (p less than 0.001). Treatment with BDP did not significantly change the responsiveness to propranolol, the geometric mean PC20 being 3.17 mg/ml bef…

Pulmonary and Respiratory MedicineAdultMaleTime FactorsMild asthmaPropranololCritical Care and Intensive Care MedicineBronchial Provocation TestsRandom AllocationDouble-Blind MethodForced Expiratory VolumeAdministration InhalationmedicineAsthmatic patientHumansAsthmaBronchial SpasmCumulative dosebusiness.industryRespiratory diseaseBeclomethasonerespiratory systemmedicine.diseaseCrossover studyPropranololAsthmaAnesthesiaBronchoconstrictionFemalemedicine.symptomCardiology and Cardiovascular Medicinebusinessmedicine.drugChest
researchProduct

Feasibility of functional magnetic resonance lung imaging in Australia with long distance transport of hyperpolarized helium from Germany.

2008

MRI of the lung using hyperpolarized helium as an inhaled contrast agent has important research applications and clinical potential. Owing to the limited availability of hyperpolarized helium, this type of imaging has not been performed in the human lung outside of North America or Europe. The objective of this study was to test the feasibility of imaging human lungs in Australia using hyperpolarized helium gas imported from Germany.A Bruker 2-Tesla whole-body magnetic resonance scanner located in Brisbane, Australia was adapted with a helium-3 radiofrequency transceiver coil. Helium-3 was hyperpolarized to 72% in Mainz, Germany and airfreighted to Brisbane. The time taken for the journey w…

Pulmonary and Respiratory MedicineAdultMalegenetic structuresContrast MediaHeliumHuman lungIsotopesGermanyLung imagingAdministration InhalationmedicineHumansmedicine.diagnostic_testbusiness.industryAustraliaMagnetic resonance imagingrespiratory systemDiagnostic ServicesMagnetic Resonance Imagingrespiratory tract diseasesHyperpolarized heliumImportant researchmedicine.anatomical_structureFeasibility StudiesNuclear medicinebusinessAviationRespirology (Carlton, Vic.)
researchProduct

Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study.

2011

SummaryRecommended treatment for moderate to severe asthma is the combination of an inhaled corticosteroid and a long-acting beta2-agonist. The present study was designed to evaluate the efficacy of a newly developed fixed combination of ciclesonide and formoterol in comparison to the marketed fixed combination of fluticasone and salmeterol in patients with moderate asthma.This was a phase II, multi-centre, randomized, parallel-group, double-blind, double-dummy study. After a 2-week run-in period, 160 patients with moderate asthma were randomized to a 6-week treatment with ciclesonide/formoterol 320/9 μg bid (CIC/F) or fluticasone propionate/salmeterol 250/50 μg bid (FP/S), both delivered a…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAdolescentUrologyCiclesonideCiclesonideFluticasone propionatechemistry.chemical_compoundYoung AdultDouble-Blind Methodimmune system diseasesPregnenedionesForced Expiratory VolumeFormoterol FumarateGermanyAdministration InhalationmedicineHumansFixed combinationAlbuterolFormoterolAnti-Asthmatic AgentsChildGlucocorticoidsFluticasoneAgedFluticasone-Salmeterol Drug Combinationbusiness.industryrespiratory systemMiddle AgedAsthmaFluticasone-Salmeterol Drug Combinationrespiratory tract diseasesBronchodilator AgentsAndrostadienesDrug CombinationsTreatment OutcomeTolerabilitychemistryEthanolaminesAustriaFormoterol FumarateFemaleSalmeterolFormoterolbusinessmedicine.drugRespiratory medicine
researchProduct